LTGO

Latigo Biotherapeutics, Inc.

• Seeking Alpha·10/02 14:15

  Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026

• TipRanks·09/08 10:01

  The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’

• Seeking Alpha·09/05 06:30

  Primary Markets Group August IPO Update

• Benzinga·09/03 21:04

  Latigo Biotherapeutics Q2 EPS $(27.59) Up From $(36.52) YoY, Sales $0.00, Same YoY

• Dow Jones·09/03 20:19

  *Latigo: Cash and Cash Equivalents Projected to Fund Operating Plans Into 2029 >LTGO

• Dow Jones·09/03 20:19

  *Latigo Biotherapeutics 2Q Loss/Shr $27.59 >LTGO

• Dow Jones·09/03 20:19

  *Latigo Biotherapeutics 2Q Loss $25.8M >LTGO

• Seeking Alpha·09/03 20:17

  Latigo Biotherapeutics, Inc. reports Q2 results

• Dow Jones·09/03 20:05

  Press Release: Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

• Dow Jones·09/03 20:05

  Press Release: Latigo Biotherapeutics Reports -2-

• TipRanks·09/02 09:00

  Analysts Offer Insights on NA Companies: Latigo Biotherapeutics, Inc. (LTGO), Golar LNG (GLNG) and Mobility Global Inc (MBGL)

• Dow Jones·09/01 18:47

  Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

• Dow Jones·09/01 18:18

  Latigo Biotherapeutics Price Target Announced at $50.00/Share by Jefferies

• Benzinga·09/01 18:08

  Jefferies Initiates Coverage On Latigo Biotherapeutics with Buy Rating, Announces Price Target of $50

• Dow Jones·09/01 12:51

  Latigo Biotherapeutics Price Target Announced at $50.00/Share by Guggenheim